Phase III HIV vaccine trial in Thailand: a step toward a protective vaccine for HIV.
The large human efficacy trail in Thailand, RV144, was concluded in the summer of 2009. This is the first Phase III trial to show limited, but significant, efficacy in preventing HIV acquisition. This trial represents the first sign that a preventive vaccine for HIV may be feasible. The vaccine regimen tested in Thailand consisted of priming with a Canarypox vector carrying three synthetic HIV genes. The priming was followed by booster inoculations with two recombinant envelope proteins from HIV, clade B and E. The need to understand the role in protection from HIV acquisition of the new responses, induced by this vaccine combination, has brought together many researchers with the common goal of improving the development of a safe and effective vaccine for HIV.
Vaccari
Monica
M
Animal Models and Retroviral Vaccine Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Poonam
Poonam
P
Franchini
Genoveffa
G
D016915:AIDS Vaccines / Q000009:adverse effects / Q000276:immunology*; D028121:Canarypox virus / Q000235:genetics; D017326:Clinical Trials, Phase III as Topic; D005822:Genetic Vectors; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D007117:Immunization, Secondary / Q000379:methods; D013785:Thailand; D014611:Vaccination / Q000379:methods
D016915:AIDS Vaccines
J Infect Dis. 1995 Jun;171(6):1623-7
7769304
Vaccine. 2004 Jan 26;22(5-6):597-606
14741150
Expert Rev Vaccines. 2004 Aug;3(4 Suppl):S75-88
15285707
Virology. 1997 May 26;232(1):98-104
9185593
AIDS Res Hum Retroviruses. 1998 Oct;14 Suppl 3:S325-31
9814961
J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Nov 1;19(3):289-95
9803972
J Virol. 2006 Apr;80(8):3732-42
16571790
J Infect Dis. 1998 May;177(5):1230-46
9593008
AIDS. 1997;11 Suppl A:S127-37
9451976
Vaccine. 1995 Apr;13(6):539-49
7483774
J Infect Dis. 1996 Nov;174(5):977-85
8896498
JAMA. 1994 Aug 10;272(6):475-80
7913731
J Virol. 2003 Oct;77(20):11220-31
14512570
Asian Pac J Allergy Immunol. 1985 Dec;3(2):195-9
2866780
Science. 1983 May 20;220(4599):868-71
6189183
Curr Opin Biotechnol. 1997 Oct;8(5):573-7
9353230
J Acquir Immune Defic Syndr. 2007 Aug 1;45(4):468-75
17496560
Mol Biol Evol. 2010 Feb;27(2):417-25
19864468
AIDS Res Hum Retroviruses. 1996 Mar 20;12(5):407-8
8882320
Tissue Antigens. 2004 Sep;64(3):251-6
15304005
J Infect Dis. 1996 Jan;173(1):52-9
8537682
J Infect Dis. 2004 Sep 1;190(5):903-7
15295694
AIDS. 1997 May;11(6):819-20
9143616
J Virol. 2002 Jan;76(1):292-302
11739694
Nat Med. 1995 Apr;1(4):321-9
7585061
JAMA. 1994 Aug 10;272(6):488-9
8040986
J Immunol. 2002 Feb 15;168(4):1847-53
11823518
Virology. 1999 Dec 5;265(1):1-9
10603312
Vaccine. 2002 May 6;20(15):1905-8
11983242
J Infect Dis. 2001 May 1;183(9):1343-52
11294665
Dev Biol Stand. 1995;84:159-63
7796949
AIDS Res Hum Retroviruses. 1996 Jul 20;12(11):985-92
8827214
Vaccine. 2001 Feb 28;19(15-16):2080-91
11228380
J Acquir Immune Defic Syndr. 2007 Sep 1;46(1):48-55
17909315
J Acquir Immune Defic Syndr. 2005 Feb 1;38(2):124-34
15671796
AIDS Res Hum Retroviruses. 2004 Jun;20(6):642-4
15242541
Vaccine. 1992;10(1):8-9
1311489
J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 15;20(5):488-94
10225232
Vaccine. 2009 Feb 11;27(7):1136-40
19071176
J Acquir Immune Defic Syndr. 2004 Nov 1;37(3):1385-92
15483468
J Infect Dis. 2004 Aug 15;190(4):702-6
15272397
AIDS. 1998;12 Suppl B:S155-61
9679641
J Virol. 2005 Oct;79(19):12321-31
16160159
AIDS. 2000 Jul 7;14(10):1365-74
10930151
Science. 2004 Jan 16;303(5656):316
14726576
N Engl J Med. 2009 Dec 3;361(23):2209-20
19843557
J Infect Dis. 2005 Mar 1;191(5):654-65
15688278
Expert Rev Vaccines. 2004 Aug;3(4 Suppl):S99-104
15285709
Virology. 2002 Dec 5;304(1):125-34
12490410
J Virol. 1999 Jun;73(6):4640-50
10233923
AIDS Res Hum Retroviruses. 1995 Aug;11(8):909-20
7492438
Lancet. 2008 Nov 29;372(9653):1881-1893
19012954
AIDS. 1998 Dec 24;12(18):2407-15
9875578
Nature. 1990 Jun 14;345(6276):622-5
2190095
J Virol. 1990 Jun;64(6):2653-9
2186175
J Infect Dis. 2006 Dec 15;194(12):1661-71
17109337
Expert Rev Vaccines. 2008 Apr;7(3):311-7
18393601
Science. 2004 Jul 9;305(5681):177-80; author reply 177-80
15247455
J Acquir Immune Defic Syndr. 2003 Jan 1;32(1):9-17
12514409
AIDS Res Hum Retroviruses. 1995 Mar;11(3):373-81
7598771
AIDS Alert. 2001 Nov;16(11):141-2, 147
11692665
Dev Biol Stand. 1995;84:165-70
7796950
PLoS Med. 2008 Aug 12;5(8):e173
18700814
AIDS. 1995 Dec;9(12):1313-22
8605050
Dev Biol Stand. 1994;82:65-9
7958484
Vaccine. 1999 Oct 1;17 Suppl 2:S65-70
10506410
AIDS. 1991 Jun;5(6):639-54
1883539
AIDS Res Hum Retroviruses. 2001 Aug 10;17(12):1175-89
11522187
IAVI Rep. 2009 Sep-Oct;13(5):4-5, 7-13, 17
20214263
J Acquir Immune Defic Syndr. 2004 Sep 1;37(1):1160-5
15319676